search icon

    Market Snapshot

    • S&P Futures

      3,809.5

    • Dow Futures

      30,868

    • Nasdaq Futures

      11,633.25

    blog search icon

    Moderna, Inc.

    (NASDAQ:MRNA)

    $142.85

    $0.04

    0.03%

    Moderna, Inc. Chart

    MRNA Stock Price Today

    Moderna, Inc. (MRNA) stock rallied over 0.03% intraday to trade at $142.85 a share on NASDAQ. The stock opened with a gain of 1.73% at $143.4 and touched an intraday high of $147.32, rising 0.03% against the last close of $142.81. The stock went to a low of $135.52 during the session.

    Stock Snapshot

    $142.81

    Prev. Close

    56.42 Billion

    Market Cap

    $135.52

    Day Low

    $143.4

    Open

    402 Million

    Number of Shares

    $147.32

    Day High

    4.20

    P/E ratio

    34.01

    EPS (TTM)

    26.63

    Cash Flow per Share

    4.31

    Free Float in %

    25.00

    Book Value

    5,622,396

    Volume

    Moderna, Inc. Historical Data

    DateOpenHighLowCloseVolume
    2022-06-30$143.4$147.32$135.52$142.855,605,378
    2022-06-29$140.425$144.36$138.618$142.812,908,100
    2022-06-28$143.4$149.79$140.95$142.193,984,900
    2022-06-27$143$146.4$138.49$145.364,392,800
    2022-06-24$143.99$144.89$138.22$144.278,478,300
    2022-06-23$136.04$143.66$132.8$143.264,721,200
    2022-06-22$127.5$139.9$126.59$136.076,044,000
    2022-06-21$130.495$134.575$129.67$129.994,321,400
    2022-06-17$120.73$128.77$120.2$128.038,352,500
    2022-06-16$124.38$125.255$118.06$121.085,720,000

    Contact Details

    200 Technology Square
    Cambridge, MA 02139
    United States

    Webiste:MRNA

    617 714 6500

    Company Information

    Employees-

    Beta1.65

    Sales or Revenue18.47 Billion

    5Y Sales Change179.40%

    Fiscal Year Ends2021-12-30

    SectorHealth Care

    IndustryBiotechnology

    About Company

    Moderna, Inc., a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally. The company has 44 development programs, which includes 26 in clinical trials across seven modalities comprising prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic intracellular therapeutics, and inhaled pulmonary therapeutics. The company has strategic alliances with AstraZeneca PLC; Merck & Co., Inc.; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Carisma Therapeutics, Inc.; Metagenomi, Inc.; the Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; and The Bill & Melinda Gates Foundation, as well as a collaboration and license agreement with Chiesi Farmaceutici S.P.A. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

    Frequently Asked Questions

    icon

    What is the current Moderna, Inc. (MRNA) stock price?

    Moderna, Inc. (NASDAQ: MRNA) stock price is $142.85 as of the last check on Thursday, June 30. During the trading session, MRNA stock reached the peak price of $147.32 while $135.52 was the lowest point it dropped to.

    icon

    MRNA's industry and sector of operation?

    The NASDAQ listed MRNA is part of Biotechnology industry that operates in the broader Health Care sector. Moderna, Inc. , a biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States and internationally.

    icon

    Who are the executives of MRNA?

    Colleen Hussey
    Sr. Mang. of Corp. Communications
    Dr. Noubar B. Afeyan Ph.D.
    Co-Founder, Independent Non Exec. Chairman & Member of Technology Advisory Board
    Mr. Stephane Bancel
    CEO & Director
    Dr. Stephen Hoge M.D.
    Pres

    icon

    What is the MRNA stock price today?

    MRNA stock traded closed the last session at $142.85, which is $0.04 or 0.03% lower than its previous close of $142.81. MRNA's current trading price is 23.56% lower than its 52-week high of $497.49 where as its distance from 52-week low of 115.61% is -71.29%.

    icon

    How many employees does MRNA have?

    Number of MRNA employees currently stands at -. MRNA operates from 200 Technology Square, Cambridge, MA 02139, United States.

    icon

    Link for MRNA official website?

    Official Webiste of $MRNA is: https://www.modernatx.com

    icon

    How do I contact MRNA?

    MRNA could be contacted at MRNA operates from 200 Technology Square, Cambridge, MA 02139, United States, or at phone #617 714 6500 and can also be accessed through its website.

    icon

    How many shares of MRNA are traded daily?

    MRNA stock volume for the day was 5,622,396 shares while in the previous session number of MRNA shares traded was 5,605,378 . The average number of MRNA shares traded daily for last 3 months was 5.97 Million.

    icon

    How much did MRNA change today?

    The percentage change in MRNA stock occurred in the recent session was 0.03% while the dollar amount for the price change in MRNA stock was $0.04.

    icon

    What price range MRNA stock been trading in?

    In the recent session, the day high for MRNA stock was $147.32 while the low for MRNA stock touched on the day was $135.52.

    icon

    What is the market cap of MRNA currently?

    The market value of MRNA currently stands at 56.42 Billion with its latest stock price at $142.85 and 402 Million of its shares outstanding.